Anti-inflammatory flurbiprofen nasal powders for nose-to-brain delivery in Alzheimer’s disease
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Anti-inflammatory flurbiprofen nasal powders for nose-to-brain delivery in Alzheimer’s disease
Authors
Keywords
-
Journal
JOURNAL OF DRUG TARGETING
Volume -, Issue -, Pages 1-11
Publisher
Informa UK Limited
Online
2019-01-29
DOI
10.1080/1061186x.2019.1574300
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- In vivo nose-to-brain delivery of the hydrophilic antiviral ribavirin by microparticle agglomerates
- (2018) Alessandro Giuliani et al. DRUG DELIVERY
- Opportunity and challenges of nasal powders: Drug formulation and delivery
- (2018) Laura Tiozzo Fasiolo et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Alzheimer’s Disease Can Be Spared by Nonsteroidal Anti-Inflammatory Drugs
- (2018) Patrick L. McGeer et al. JOURNAL OF ALZHEIMERS DISEASE
- Nose-to-brain drug delivery: An update on clinical challenges and progress towards approval of anti-Alzheimer drugs
- (2018) Mukta Agrawal et al. JOURNAL OF CONTROLLED RELEASE
- NSAID Exposure and Risk of Alzheimer's Disease: An Updated Meta-Analysis From Cohort Studies
- (2018) Caixia Zhang et al. Frontiers in Aging Neuroscience
- Insulin Resistance as a Therapeutic Target in the Treatment of Alzheimer's Disease: A State-of-the-Art Review
- (2018) Christian Benedict et al. Frontiers in Neuroscience
- Towards Standardized Dissolution Techniques for In Vitro Performance Testing of Dry Powder Inhalers
- (2018) Andreea Floroiu et al. DISSOLUTION TECHNOLOGIES
- Dynamic dissolution-/permeation-testing of nano- and microparticle formulations of fenofibrate
- (2017) Daniel Sironi et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Early and Late CNS Inflammation in Alzheimer’s Disease: Two Extremes of a Continuum?
- (2017) A. Claudio Cuello TRENDS IN PHARMACOLOGICAL SCIENCES
- Synthesis of Ibuprofen Conjugated Molecular Transporter Capable of Enhanced Brain Penetration
- (2017) Goutam Biswas et al. Journal of Chemistry
- Why Did Tarenflurbil Fail in Alzheimer's Disease?
- (2017) Bruno P. Imbimbo JOURNAL OF ALZHEIMERS DISEASE
- Aerodynamic properties, solubility and in vitro antibacterial efficacy of dry powders prepared by spray drying: Clarithromycin versus its hydrochloride salt
- (2016) Michele Dario Manniello et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Nasal powders of thalidomide for local treatment of nose bleeding in persons affected by hereditary hemorrhagic telangiectasia
- (2016) G. Colombo et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Intranasal Delivery of Proteins and Peptides in the Treatment of Neurodegenerative Diseases
- (2015) M. Elizabeth Meredith et al. AAPS Journal
- Non-Steroidal Anti-Inflammatory Drugs as a Treatment for Alzheimer’s Disease: A Systematic Review and Meta-Analysis of Treatment Effect
- (2015) Marina Miguel-Álvarez et al. DRUGS & AGING
- Spray-dried amikacin sulphate powder for inhalation in cystic fibrosis patients: The role of ethanol in particle formation
- (2015) Silvia Belotti et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Neuroinflammation in Alzheimer's disease
- (2015) Michael T Heneka et al. LANCET NEUROLOGY
- Effect of inlet temperature on physicochemical properties of spray-dried jamun fruit juice powder
- (2015) Swaminathan Santhalakshmy et al. POWDER TECHNOLOGY
- Role of Traditional Nonsteroidal Anti-inflammatory Drugs in Alzheimer’s Disease
- (2014) Prem Prakash Gupta et al. American Journal of Alzheimers Disease and Other Dementias
- Nasal NSAIDs for Alzheimer's Disease
- (2014) Steven Lehrer American Journal of Alzheimers Disease and Other Dementias
- Spray dried amikacin powder for inhalation in cystic fibrosis patients: A quality by design approach for product construction
- (2014) Silvia Belotti et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Neuroinflammation in Alzheimer’s Disease: from Pathogenesis to a Therapeutic Target
- (2014) Sanjay W. Pimplikar JOURNAL OF CLINICAL IMMUNOLOGY
- Alzheimer disease in the United States (2010-2050) estimated using the 2010 census
- (2013) L. E. Hebert et al. NEUROLOGY
- Nanoparticulate flurbiprofen reduces amyloid-β42 generation in an in vitro blood–brain barrier model
- (2013) Sabrina Meister et al. Alzheimers Research & Therapy
- Dry powder inhalers of gentamicin and leucine: formulation parameters, aerosol performance and in vitro toxicity on CuFi1 cells
- (2012) R.P. Aquino et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Antidiuretic effect of desmopressin chimera agglomerates by nasal administration in rats
- (2012) Anna Giulia Balducci et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Particles and powders: Tools of innovation for non-invasive drug administration
- (2012) Francesca Buttini et al. JOURNAL OF CONTROLLED RELEASE
- Enhanced technological and permeation properties of a microencapsulated soy isoflavones extract
- (2012) Francesca Sansone et al. JOURNAL OF FOOD ENGINEERING
- A Review: Inflammatory Process in Alzheimer's Disease, Role of Cytokines
- (2012) Jose Miguel Rubio-Perez et al. TheScientificWorldJOURNAL
- Brain distribution of ribavirin after intranasal administration
- (2011) Gaia Colombo et al. ANTIVIRAL RESEARCH
- Impact of the counterion on the solubility and physicochemical properties of salts of carboxylic acid drugs
- (2011) S.E. David et al. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
- Nano spray drying: A novel method for preparing protein nanoparticles for protein therapy
- (2010) Sie Huey Lee et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Agglomerates Containing Pantoprazole Microparticles: Modulating the Drug Release
- (2009) Renata P. Raffin et al. AAPS PHARMSCITECH
- In vitro permeation of desmopressin across rabbit nasal mucosa from liquid nasal sprays: The enhancing effect of potassium sorbate
- (2009) Bortolotti Fabrizio et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Tarenflurbil: a shot on goal
- (2008) Paul S Aisen LANCET NEUROLOGY
- Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomised phase II trial
- (2008) Gordon K Wilcock et al. LANCET NEUROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search